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Yanping Cheng, MD,* Jenn C. McGregor, BS,* Edward A. Estrada, BSME,y Juan F. Granada, MD,*
Greg L. Kaluza, MD, PHD*W e present an illustrative case of vas-cular restoration by a bioresorbable scaf-fold (BRS) in an experimental setting
(Figure 1). The case illustrates the inherent ability of
BRS to allow a more physiological long-term resolu-
tion of the adverse hemodynamic, mechanical, and
biological effects of vessel stenting, which is ampli-
ﬁed by the absence of atherosclerosis in the animal
model. Healthy porcine arteries have previously
demonstrated late lumen gain evident around 12
months after treatment with non-drug-eluting (1)
and drug-eluting (2) BRS. As the scaffold degrades,
the treated segment is unrestrained in its ability
to remodel positively by the presence of plaque
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lumen gain. However, late lumen gain also occurs
in patients treated with BRS despite underlying
atherosclerosis; it was ﬁrst reported in the 2-year
multimodality imaging outcomes of the ABSORB
(A Bioabsorbable Everolimus-Eluting Coronary Stent
System) trial (3). This unique property of BRS may
result in a favorable impact on the long-term risk of
restenosis and neoatherosclerosis in the stented
segment.
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FIGURE 1 Tandemly Deployed Non-Drug-Eluting BRS and Bare-Metal Stent in RCA of Yucatan Miniswine
A non-drug-eluting bioresorbable scaffold (BRS) (Amaranth Medical, Mountain View, California) and a bare-metal stent (BMS) (Liberté Boston
Scientiﬁc, Natick, Massachusetts) were deployed in a tandem fashion in the distal segment of a normal right coronary artery (RCA) in the
Yucatan miniswine as shown in the post-implantation angiogram (A). Post-implantation optimal coherence tomography (OCT) showed
adequately uniform lumen and smooth transition from BRS to BMS in the long-axis view (B) and adequate apposition of the overlapping stents
in the short-axis view (C). At 1-year follow-up, angiography demonstrated a mild narrowing and lumen loss of the distal segment “caged” by
BMS including most of the overlapping area. Whereas, the proximal segment with nonoverlapped BRS portion displayed positive remodeling
and late lumen gain (D). The same effect can be clearly appreciated in the long-axis view of the OCT (E), with minimal neointimal proliferation
in the overlapped segment in the short-axis view of the OCT (F).
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